Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for inflammation in experimentally-induced insomnia
NCT02268565Phase 1Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2014
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Insomnia comparing Aspirin with Placebo (2 arms). Primary endpoint: Inflammatory markers at 5 days. Started Oct 2014; status: completed.
02
Drugs
aspirin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02268565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268565.